Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | AURKA | O14965 | 1/20 | 1.00 |
| ▸ | PDPK1 | O15530 | 1/20 | 1.00 |
| ▸ | JAK2 | O60674 | 1/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | EGFR | P00533 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | LYN | P07948 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niclosamide SCHEMBL6662409 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL27365268 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL29363878 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL28313524 | 1.00 | KMT2A (1.00) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL2061202 | 0.99 | KMT2A (0.97) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL27937315 | 0.99 | KMT2A (0.97) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL31098821 | 0.99 | KMT2A (0.97) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL16686086 | 0.97 | KMT2A (0.95) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL1526777 | 0.97 | KMT2A (0.95) | KMT2AMEN1MAPTSMN1; SMN2NPC1 | |
| Niclosamide SCHEMBL23753582 | 0.94 | LMNA (0.89) | KMT2AMEN1MAPTSMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15944 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144251-A1 | ANTIMICROBIAL NANOCLAYS COMPRISING CATIONIC ANTIMICROBIALS, METHOD OF PREPARATION AND USES THEREOF | POLYAMYNA NANOTECH INC. (CA) | 2026-05-28 | — | — | US | claimed |
| US-12636267-B2 | Niclosamide delayed-release composition and antiviral use thereof | DAEWOONG THERAPEUTICS INC. (KR) | 2026-05-26 | — | — | US | claimed |
| US-20260139860-A1 | PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2026-05-21 | — | — | US | claimed |
| US-20260139320-A1 | StarTrace: A Multiplex Drug Testing Platform for Personalized Medicine | UNIV OF SOUTH CAROLINA (US) | 2026-05-21 | — | — | US | claimed |
| CN-122070133-A | Pharmaceutical compositions containing androgen receptor inhibitors/antagonists, methods and uses | 苏州开拓药业股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4572767-B1 | COMBINATION OF NICLOSAMIDE AND SPIRONOLACTONE FOR USE IN THE TREATMENT OF FCOV INFECTION OR FELINE INFECTIOUS PERITONITIS | IMUNEKS FARMA ILAC SAN VE TIC A S (TR) | 2026-05-06 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| WO-2026088112-A1 | COMBINATION THERAPIES WITH AR-DEGRADING AGENTS AND PSMA-TARGETING RADIOLIGANDS | NOVARTIS AG (CH) | 2026-04-30 | — | — | WO | claimed |
| US-20260108480-A1 | METHODS FOR INDUCING PROLIFERATION OF STEM CELLS | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-04-23 | — | — | US | claimed |
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | claimed |
| EP-0314846-B1 | ANIMAL REPELLENT COMPOSITION AND METHOD | R & C PRODUCTS PTY. LIMITED (AU) | 1991-04-17 | — | — | EP | claimed |
| US-4940583-A | Animal repellent composition and method | R & C PRODUCTS PTY. LIMITED (AU) | 1990-07-10 | — | — | US | claimed |
| EP-0314846-A1 | Animal repellent composition and method | R & C PRODUCTS PTY. LIMITED (AU) | 1989-05-10 | — | — | EP | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| EP-0059074-B1 | ANTHELMINTIC COMPOSITION AND THE USE THEREOF | SANKYO COMPANY LIMITED (JP) | 1984-10-10 | — | — | EP | claimed |
| US-4468390-A | Anthelmintic composition and the use thereof | SANKYO COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| US-4353962-A | USING AN ACRYLIC POLYMER | ENVIRONMENTAL CHEMICALS, INC. (US) | 1982-10-12 | — | — | US | claimed |
| EP-0059074-A1 | Anthelmintic composition and the use thereof | SANKYO COMPANY LIMITED (JP) | 1982-09-01 | — | — | EP | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4283400-A | Medicated animal feed based on liver meal | BAYER AKTIENGESELLSCHAFT (DE) | 1981-08-11 | — | — | US | claimed |